-
FDA Virtual Public Meeting: Draft Amended Environmental Assessment for AquAdvantage Salmon
FDA Virtual Public Meeting: Draft Amended Environmental Assessment for AquAdvantage Salmon
The FDA has announced the availability of a draft amended Environmental Assessment (EA) for an approved application concerning Atlantic salmon with an intentionally altered genome, and a subsequent virtual public meeting, entitled “Public Meeting on Draft Amended Environmental Assessment for Production of AquAdvantage Salmon at the Bay Fortune and Rollo Bay Facilities on Prince Edward […]